Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sun, 03/24/13 - 12:27 pm
JNJ
Invokana
type 2 diabetes
diabetes
pulmonary arterial hypertension
Treprostinil
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha
Sat, 03/9/13 - 12:29 pm
type 2 diabetes
JNJ
diabetes
canagliflozin
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg
Wed, 03/6/13 - 09:59 am
Takeda
Actos
diabetes
type 2 diabetes
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Yahoo/BusinessWire
Wed, 03/6/13 - 09:44 am
Santarus
type 2 diabetes
Cycloset
VeroScience
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Sat, 03/2/13 - 04:00 pm
pancreatitis
diabetes
type 2 diabetes
Merck
AstraZeneca
Bristol-Myers Squibb
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Sat, 02/16/13 - 12:23 pm
type 2 diabetes
Takeda
diabetes
cancer
Actos
Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
PharmaLive
Sat, 02/16/13 - 12:16 pm
Oramed Pharmaceuticals
oral insulin
type 1 diabetes
type 2 diabetes
ORMD-0801
ORMD-0901
FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com
Sun, 01/27/13 - 11:35 am
type 2 diabetes
Takeda
diabetes
alogliptin
Furiex Pharmaceuticals
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Sun, 01/27/13 - 11:25 am
Takeda
diabetes
type 2 diabetes
Actos
alogliptin
Furiex Pharmaceuticals
Can J&J Get Its Diabetes Drug Past the Safety-First FDA?
Motley Fool
Sat, 01/12/13 - 11:05 am
JNJ
canagliflozin
diabetes
type 2 diabetes
This Undervalued Pharma Is Ready To Move Higher
Motley Fool
Sat, 12/8/12 - 11:28 am
AstraZeneca
type 2 diabetes
Forixga
Dapagliflozin
Long MannKind's Afrezza: Shares Versus A Bull Call Spread
Seeking Alpha
Sat, 12/1/12 - 09:33 am
MannKind
Afrezza
inhaled insulin
diabetes
type 1 diabetes
type 2 diabetes
Medtronic, Dexcom and Abbott Offer New Products to a Growing Diabetic Population in Europe, a €5 Billion + Market
Tue, 11/27/12 - 11:27 pm
diabetes
type 2 diabetes
Medtronic
Abbott Laboratories
DexCom
New Diabetes Drug Can Bolster J&J’s $74 Value
Trefis
Sat, 10/6/12 - 12:05 pm
JNJ
diabetes
canagliflozin
type 2 diabetes
Extending the Diabetes Dominance
Motley Fool
Sat, 10/6/12 - 11:49 am
Merck
MK-3102
Januvia
diabetes
type 2 diabetes
Takeda's Actos era ends with generic launches
Fierce Pharma
Sat, 08/18/12 - 04:02 pm
Takeda
Actos
diabetes
type 2 diabetes
generics
3 Reasons This Speculative Bio-Pharma Is A Winner
Seeking Alpha
Sat, 08/11/12 - 11:30 am
MannKind
Afrezza
diabetes
type 1 diabetes
type 2 diabetes
Rottenstein Law Group Disturbed by Takeda Pharmaceutical’s Resubmission of Regulatory Approval Application for Actos-Containing Drug
Digital Journal
Sat, 08/4/12 - 12:49 pm
Takeda
Actos
diabetes
type 2 diabetes
Furiex Confirms Takeda's Resubmissions Of Alogliptin NDAs To FDA
NASDAQ
Sun, 07/29/12 - 01:03 pm
Furiex Pharmaceuticals
Takeda
alogliptin
diabetes
type 2 diabetes
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »